IL137865A0 - Method for the diagnosis and follow-up of schizophrenia - Google Patents

Method for the diagnosis and follow-up of schizophrenia

Info

Publication number
IL137865A0
IL137865A0 IL13786500A IL13786500A IL137865A0 IL 137865 A0 IL137865 A0 IL 137865A0 IL 13786500 A IL13786500 A IL 13786500A IL 13786500 A IL13786500 A IL 13786500A IL 137865 A0 IL137865 A0 IL 137865A0
Authority
IL
Israel
Prior art keywords
individual
schizophrenia
mrna
healthy
diagnosis
Prior art date
Application number
IL13786500A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL13786500A priority Critical patent/IL137865A0/xx
Priority to US10/344,862 priority patent/US20050158715A1/en
Priority to AT01961078T priority patent/ATE355389T1/de
Priority to AU2001282456A priority patent/AU2001282456A1/en
Priority to EP01961078A priority patent/EP1364050B1/de
Priority to PCT/IL2001/000761 priority patent/WO2002014547A2/en
Priority to DE60126991T priority patent/DE60126991T2/de
Priority to IL15442901A priority patent/IL154429A0/xx
Publication of IL137865A0 publication Critical patent/IL137865A0/xx
Priority to IL154429A priority patent/IL154429A/en
Priority to US12/490,195 priority patent/US7939262B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Fuel Cell (AREA)
  • Heat-Pump Type And Storage Water Heaters (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
IL13786500A 2000-08-15 2000-08-15 Method for the diagnosis and follow-up of schizophrenia IL137865A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IL13786500A IL137865A0 (en) 2000-08-15 2000-08-15 Method for the diagnosis and follow-up of schizophrenia
US10/344,862 US20050158715A1 (en) 2000-08-15 2001-08-15 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders
AT01961078T ATE355389T1 (de) 2000-08-15 2001-08-15 Verfahren zur diagnose von schizophrenie
AU2001282456A AU2001282456A1 (en) 2000-08-15 2001-08-15 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders
EP01961078A EP1364050B1 (de) 2000-08-15 2001-08-15 Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE
PCT/IL2001/000761 WO2002014547A2 (en) 2000-08-15 2001-08-15 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders
DE60126991T DE60126991T2 (de) 2000-08-15 2001-08-15 Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE
IL15442901A IL154429A0 (en) 2000-08-15 2001-08-15 Method for the diagnosis and follow-up of schizophrenia and other mental and neurodegenerative disorders
IL154429A IL154429A (en) 2000-08-15 2003-02-13 A method for diagnosing schizophrenia
US12/490,195 US7939262B2 (en) 2000-08-15 2009-06-23 Method for the diagnosis of schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13786500A IL137865A0 (en) 2000-08-15 2000-08-15 Method for the diagnosis and follow-up of schizophrenia

Publications (1)

Publication Number Publication Date
IL137865A0 true IL137865A0 (en) 2001-10-31

Family

ID=11074527

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13786500A IL137865A0 (en) 2000-08-15 2000-08-15 Method for the diagnosis and follow-up of schizophrenia
IL154429A IL154429A (en) 2000-08-15 2003-02-13 A method for diagnosing schizophrenia

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154429A IL154429A (en) 2000-08-15 2003-02-13 A method for diagnosing schizophrenia

Country Status (7)

Country Link
US (2) US20050158715A1 (de)
EP (1) EP1364050B1 (de)
AT (1) ATE355389T1 (de)
AU (1) AU2001282456A1 (de)
DE (1) DE60126991T2 (de)
IL (2) IL137865A0 (de)
WO (1) WO2002014547A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
AU2003211947A1 (en) * 2002-02-20 2003-09-09 Sysmex Corporation PRIMERS FOR NUCLEIC ACID AMPLIFICATION IN DETECTING HOUSEKEEPING GENE mRNA AND TEST METHOD USING THESE PRIMERS
HU227246B1 (en) * 2004-04-30 2010-12-28 Szegedi Biolog Koezpont Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit
US20080075789A1 (en) * 2006-02-28 2008-03-27 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
WO2009074331A2 (en) * 2007-12-11 2009-06-18 Julius-Maximilians-Universität Würzburg Early and differential diagnosis test for alzheimer's disease
AT515576B1 (de) * 2014-03-14 2017-09-15 Red Bull Gmbh Methode zur in vitro Diagnose des Grades an Geistesschwäche im Down-Syndrom
US20200168317A1 (en) 2018-08-22 2020-05-28 Centre For Addiction And Mental Health Tool for assisting individuals experiencing auditory hallucinations to differentiate between hallucinations and ambient sounds
US11862337B2 (en) 2019-03-19 2024-01-02 Cambridge Cognition Limited Method and uses of diagnosing and recommending treatment for a psychotic disorder
CN116528747A (zh) * 2020-08-17 2023-08-01 纽约市哥伦比亚大学理事会 神经黑色素敏感性mri作为多巴胺功能的生物标志物的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby

Also Published As

Publication number Publication date
ATE355389T1 (de) 2006-03-15
WO2002014547A3 (en) 2003-10-02
US20100041043A1 (en) 2010-02-18
US7939262B2 (en) 2011-05-10
IL154429A (en) 2009-09-22
AU2001282456A1 (en) 2002-02-25
US20050158715A1 (en) 2005-07-21
DE60126991D1 (de) 2007-04-12
EP1364050A2 (de) 2003-11-26
EP1364050B1 (de) 2007-02-28
WO2002014547A2 (en) 2002-02-21
DE60126991T2 (de) 2008-01-03

Similar Documents

Publication Publication Date Title
WO2000001845A3 (de) Verfahren zur frühen diagnose von carcinomen
WO2005096762A3 (en) Systems and methods of electronic trading using automatic book updates
WO2002077604A3 (en) Labeled cells for use as an internal functional control in rare cell detection assays
WO2002043758A3 (en) Uses of mammalian genes and related reagents
WO2002099598A3 (en) System and method for rapid updating of credit information
AU2002365421A1 (en) Methods and compositions for detecting the activation state of the multiple proteins in single cells
WO2004046098A3 (en) Method for predicting autoimmune diseases
AU2002341191A1 (en) Diagnosis of clinical infection of a wound
WO2003047420A3 (en) Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
WO2002067760A3 (en) Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
WO2004091523A3 (en) Method for identifying ligands specific for structural isoforms of proteins
WO2003046009A1 (en) ANTI-IL13 RECEPTOR α1 NEUTRALIZING ANTIBODY
SE9604815D0 (sv) A metod of diagnosis
AU2001282456A1 (en) Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders
WO2007016367A3 (en) Neoplastic disease-related methods, kits, systems and databases
WO1999057306A3 (en) Method for diagnosing a vascular condition
WO2004015420A8 (en) Method for diagnosing multiple sclerosis
WO2005070086A3 (en) Methods and compositions for determining a graft tolerant phenotype in a subject
AU6415000A (en) Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay
WO2003019136A3 (en) Methods for inhibiting angiogenesis
WO2001092877A3 (en) Method of identifying and/or isolating stem cells
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
EP2071338A3 (de) Menschliche Diabetes-vermittelnde Proteine
DE69623280D1 (de) Inhibierung der amulin-freisetzung
WO2003047526A3 (en) Cell adhesion and extracellular matrix proteins